The report outlines Legend Biotech's inaugural ESG report focusing on their commitment to delivering transformative innovations while prioritizing ethical business practices, employee engagement, and sustainable environmental management. Key highlights include their commitment to developing cutting-edge cell therapies, including CARVYKTI®, collaborating with partners like Janssen and Novartis, expanding their global commercial presence, investing in research and development, and supporting various community initiatives.
Issuing Company Legend Biotech Corp
Report Type Sustainability Report
Report Language EN
Report Filesize 14.27 MB
No. of Pages 41 pages
Reporting periodJanuary 1, 2023-December 31, 2023
Report Edition1
Assurance Provider Unknown
Reporting Standards SASB
Materiality Assessmenttrue
